Mineralys director Brian Taylor Slingsby disposes of 104,320 common shares for $3 million

Bitget2026/09/25 01:50

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Mineralys Therapeutics director Brian Taylor Slingsby disclosed a sale of 104,320 common shares on Sep. 22, 2026.
Transaction price was USD 28.8085 per share.
Indirect holdings stood at 7,805,718 shares following the sale.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Mineralys Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001963901-26-000003), on September 24, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Mineralys director Brian Taylor Slingsby disposes of 104,320 common shares for $3 million

You may also like

Crypto prices